title: IBD in 2016: Biologicals and biosimilars in IBD - the road to personalized treatment.
authors.affiliation: First Department of Medicine, Semmelweis University, Koranyi Sandor str. 2/a, 1083 Budapest, Hungary.
authors.forename: Krisztina B
authors.initials: KB
authors.lastname: Gecse
authors.affiliation: First Department of Medicine, Semmelweis University, Koranyi Sandor str. 2/a, 1083 Budapest, Hungary.
authors.forename: Péter L
authors.initials: PL
authors.lastname: Lakatos
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D045164:Mesenchymal Stem Cell Transplantation; D057285:Precision Medicine
chemical_list: D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals; C000591237:CT-P13